Examining Amyloid Reduction As a Surrogate Endpoint Through Latent Class Analysis Using Clinical Trial Data for Dominantly Inherited Alzheimer's Disease.
ALZHEIMERS & DEMENTIA（2024）
关键词
autosomal dominant Alzheimer's disease,Dominantly Inherited Alzheimer Network,gantenerumab,latent class analysis,solanezumab,surrogate biomarker
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要